Details for New Drug Application (NDA): 020346
✉ Email this page to a colleague
The generic ingredient in ZYRTEC is cetirizine hydrochloride; pseudoephedrine hydrochloride. There are thirty-nine drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the cetirizine hydrochloride; pseudoephedrine hydrochloride profile page.
Summary for 020346
Tradename: | ZYRTEC |
Applicant: | J And J Consumer Inc |
Ingredient: | cetirizine hydrochloride |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 020346
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION;ORAL | Strength | 5MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Sep 27, 1996 | TE: | RLD: | No |
Expired US Patents for NDA 020346
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
J And J Consumer Inc | ZYRTEC | cetirizine hydrochloride | SOLUTION;ORAL | 020346-001 | Sep 27, 1996 | 4,525,358*PED | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription